Real-time enrollment status for this idiopathic pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:12 PM UTC
| NCT Number | NCT06967805 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Pulmonary Fibrosis |
| Phase | PHASE2 |
| Target Enrollment | 164 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Mediar Therapeutics |
| Last Updated on CT.gov | June 12, 2026 (Jun 12, 2026) |
As of July 18, 2026: Clinical trial NCT06967805 is currently recruiting participants. This phase2 study for idiopathic pulmonary fibrosis is actively seeking new participants at 26 locations across the United States. The study is sponsored by Mediar Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06967805 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06967805 was last updated Jun 12, 2026 (June 12, 2026). HelloStudys verifies this status automatically.